Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

HomeBAXTERSharesource 2.0 Telehealth Platform Launch by Baxter

Sharesource 2.0 Telehealth Platform Launch by Baxter

To Support Greater Clinical Insights and Personalized Peritoneal Dialysis Care

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today the launch of the Sharesource 2.0 clinical portal to give healthcare providers greater insights to their patients’ home peritoneal dialysis (PD) treatments, while offering improved clinic workflow. Healthcare providers will now receive more comprehensive patient treatment summaries from the remote patient management platform, including trending ultrafiltration data, so they can make better informed and more timely treatment decisions.

Sharesource 2.0 Telehealth PlatformSharesource, the most widely adopted telehealth platform globally for home dialysis, has helped manage more than 7 million PD treatments in more than 40 countries. Supporting its broad adoption, there is growing evidence the remote patient management technology assists healthcare providers with early detection and intervention of catheter issues1,2,3,4, peritonitis5, and adherence-related6,7,8 complications, which can lead to reduced hospitalizations9.

“While the global patient population requiring dialysis is growing, the number of clinicians and their resources are not increasing,” says Laura Angelini, general manager, Baxter’s Renal Care business. “For this reason, we are committed to transforming renal care through meaningful innovations like Sharesource that support better care options for both clinicians and patients.”

Sharesource 2.0 Telehealth Platform features a new clinical dashboard that provides:

  • A more comprehensive patient treatment summary to enable faster clinical insights
  • Trending total ultrafiltration data to help make informed decisions about treatment effectiveness
  • Improved workflow to triage and review patient dashboards faster

In a recent independent, observational study, “Longitudinal Experience with Remote Monitoring for Automated Peritoneal Dialysis Patients,” in Nephron Clinical Practice, 2019, researchers described how the PD center at San Bortolo Hospital (Vicenza, Italy) altered its clinical practice following the implementation of remote patient management with Sharesource.

The study observed 43 patients using Baxter’s HomeChoice Claria with Sharesource over a one-year period, compared to a historical control (42 patients on automated peritoneal dialysis (APD) without Sharesource). They found prescription changes for patients managed with Sharesource nearly doubled, while night alarms and in-person visits were significantly reduced. Further findings indicated remote patient management supports significant time savings—approximately 105 hours per year—for the physicians and nurses collectively at the San Bortolo Hospital. This suggests remote patient management can achieve time and cost savings for providers and patients by allowing for a more personalized therapy regime and early detection and resolution of technical problems.

The Sharesource 2.0 update is live on Baxter’s Amia and HomeChoice Claria APD systems across Europe, Canada, Latin America and the United States, and will be live later this year across Asia where Kaguya and HomeChoice Claria are available.


Reference

1 Jiménez S & Condia J. Abstract presented at 17th ISPD congress. Vancouver (Canada). 2018. [P-337]
2 Garcia I, et al. Abstract presented at 13th Euro-PD congress. Dublin (Ireland). 2017. [P-63]
3 Jotterand Drepper V, et al. Abstract presented at ASN Kidney Week congress. Chicago (US). 2016. [SA-PO023]
4 Rojas-Diaz M, et al. Abstract presented at ASN Kidney Week congress. New Orleans (US). 2017. [PUB344]
5 Gomez R, et al. Abstract presented at 13th Euro-PD congress. Dublin (Ireland). 2017. [P-222]
6 Jiménez S & Condia J. Abstract presented at 17th ISPD congress. Vancouver (Canada). 2018. [P-229]
7 Firanek C, et al. Abstract presented at 54th ERA-EDTA congress. Madrid (Spain). 2017. [MP557]
8 Jotterand Drepper V, et al. Perit Dial Int. 2018; 38:76–78; 10. Rojas-Diaz M & Ramos A. Abstract presented at ASN Kidney Week congress. New Orleans (US). 2017. [TH-PO859]
9 Rivera A, et al. Abstract presented at ASN Kidney Week congress. San Diego (US). 2018. [FR-PO683]
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy